Background macular Shape Background macular Shape Background macular Shape
Grants > Regeneration of Cone Photoreceptors in the Human Retina Updated On: Ene. 21, 2025
Macular Degeneration Research Grant

Regeneration of Cone Photoreceptors in the Human Retina

Regenerating Cells Damaged by Macular Degeneration
Juliette Wohlschlegel, PhD

Principal Investigator

Juliette Wohlschlegel, PhD

University of Washington

Seattle, WA, USA

About the Research Project

Program

Macular Degeneration Research

Award Type

Postdoctoral Fellowship

Award Amount

$191,339

Active Dates

July 01, 2024 - June 30, 2026

Grant ID

M2024005F

Mentor(s)

Tom Reh, PhD, University of Washington

Goals

This project aims to reprogram Müller glia, a support cell in the retina, into functional cone photoreceptors to replace those that progressively degenerate in macular degeneration.

Summary

The human retina cannot regenerate after diseases like age-related macular degeneration, which often leads to blindness. However, a few species including fish can regenerate new retinal cells that eventually restore visual function. The regenerative process is driven by the Müller glia, a support cell in the retina. Researchers are now partially able to recapitulate this phenomenon in the human retina. Using this new strategy, they plan to test the regenerative capacity of a specific zone of the human retina: the macula. Dr. Wohlschlegel and her team next propose to test different factors to specifically stimulate cone photoreceptor regeneration from Müller glia.

Unique and Innovative

In the field of regenerative medicine for AMD, most of the efforts focus on using stem cell transplants to replace damaged cells, though there are significant barriers to the integration of transplanted cells. We propose an alternative strategy that consists of stimulating the intrinsic regenerative capacity of the retina. The potential of human Muller glia to regenerate cone photoreceptors in a 3D in vitro model (retinal organoids and fetal retinal cultures) is a new regenerative medicine approach and has significant advantages over transplants, including abrogating the need for immunosuppressors.

Foreseeable Benefits

The ability to regenerate functional neurons from endogenous glial cells provides a new avenue for developing therapeutic strategies for the treatment of human retinal diseases including AMD. Findings from this proposal will allow us to potentially derive photoreceptors from human Muller glia and thus will provide the groundwork to translate these methods to clinical application to restore vision in individuals suffering from retinal diseases.